Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Short-acting sedative-hypnotic presented at Neuroscience meeting

Nov. 14, 2007

Phase I study results for ARC-1779 in healthy volunteers available

Nov. 14, 2007

LY-518674 increases apo A-I production but not HDL cholesterol in metabolic syndrome patients

Nov. 14, 2007

Post hoc analyses of IDEAL, SPARCL studies show additional benefits of atorvastatin

Nov. 14, 2007

Ferric carboxymaltose injection shows promise in non-dialysis-dependent CKD anemia

Nov. 14, 2007

Preliminary study results show FG-4592 well tolerated in CKD anemia

Nov. 14, 2007

HNE scavengers may have potential in AD

Nov. 14, 2007

Docetaxel/telatinib combination shows promise in cancer patients

Nov. 14, 2007

VioQuest cancer agents progress through early studies

Nov. 14, 2007

Novel alpha3 subunit-preferring GABA-A receptor allosteric activator profiled by Neurogen

Nov. 13, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...